Corient Private Wealth
RDY icon

Corient Private Wealth’s Dr. Reddy's Laboratories RDY Stock Holding History

Corient Private Wealth’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Buy
209,792
+29,819
+17% +$402K ﹤0.01% 1116
2026
Q1 		$2.48M Buy
179,973
+35,003
+24% +$487K ﹤0.01% 1156
2025
Q4 		$2.04M Sell
144,970
-13,756
-9% -$193K ﹤0.01% 1143
2025
Q3 		$2.22M Buy
158,726
+36,959
+30% +$532K ﹤0.01% 1017
2025
Q2 		$1.83M Buy
121,767
+4,410
+4% +$63K ﹤0.01% 1075
2025
Q1 		$1.55M Sell
117,357
-39,981
-25% -$552K ﹤0.01% 1075
2024
Q4 		$2.48M Buy
157,338
+13,598
+9% +$204K ﹤0.01% 916
2024
Q3 		$2.28M Sell
143,740
-1,965
-1% -$31.6K ﹤0.01% 1035
2024
Q2 		$2.22M Buy
145,705
+5,660
+4% +$81.1K ﹤0.01% 982
2024
Q1 		$2.05M Buy
140,045
+890
+0.6% +$13K ﹤0.01% 1007
2023
Q4 		$1.94M Sell
139,155
-6,515
-4% -$87.1K ﹤0.01% 1018
2023
Q3 		$1.95M Sell
145,670
-2,175
-1% -$29.4K ﹤0.01% 929
2023
Q2 		$1.87M Buy
147,845
+29,050
+24% +$339K ﹤0.01% 926
2023
Q1 		$1.35M Buy
118,795
+57,870
+95% +$625K ﹤0.01% 978
2022
Q4 		$631K Buy
+60,925
New +$657K ﹤0.01% 1070

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Corient Private Wealth's RDY Position: Q2 2026 in Review

Corient Private Wealth increased its Dr. Reddy's Laboratories (RDY) stake by 17% in Q2 2026, buying an estimated $402K and bringing the position to 209,792 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1116.

Corient Private Wealth first reported a position in RDY in Q4 2022 and has held it in 15 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Corient Private Wealth held 209,792 shares of Dr. Reddy's Laboratories worth $3.04M as of Q2 2026.
  • Corient Private Wealth bought 29,819 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $402K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1116 holding.
  • Corient Private Wealth first reported a position in Dr. Reddy's Laboratories in Q4 2022 and has held it in 15 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.